The healthcare giant’s separation of its consumer-health business arms it with billions in cash for allocating capital in the remaining…
Net earnings at the pharmaceutical company rose 6.9% to $5.14 billion, or $1.96 a share. Source link
A surprisingly early distribution and a stretched valuation hit J&J’s consumer health arm hard. Source link